GFN•TV: News and Interviews

Join us for a fast-moving roundup of the most significant tobacco harm reduction developments of 2025. From FCTC COP11 controversies and global bans to new scientific insights, advocacy efforts, and major policy shifts, Will Godfrey breaks down the year’s biggest stories. Discover where progress is being made, where setbacks continue, and how real-world consumers are shaping the future of safer nicotine.

Join GFN.TV and Michael Landl from the World Vapers Alliance as they break down COP11’s impact on tobacco harm reduction. Discover how countries challenged WHO recommendations, delayed restrictive measures, and pushed for evidence-based policies. Learn what this means for EU regulations, harm reduction strategies, and the global fight for safer nicotine alternatives.

Join Joanna Junak on GFN News as she speaks with Kurt Yeo, co-founder of Vaping Saved My Life, about the key moments and conversations surrounding COP11. Kurt shares his impressions from the unofficial Good COP 2.0 meeting in Geneva and offers insights into the broader discussions on harm reduction and tobacco policy.

Next in our Science Lab sessions, Chloe Rose PhD presents on the importance of properly designed studies and trials to determine the safety and relative risk of nicotine products.

In this exclusive GFN News interview, Joanna Junak speaks with Nancy Loucas, CAPHRA Executive Coordinator, about the fallout from COP11 in Geneva and the controversial Dirty Ashtray Award given to New Zealand.

Misunderstanding nicotine delivery: a discussion on nicotine pouches. PMI's Carrie Wade and Gizelle Baker discuss the problems with comparing nicotine content of pouches with combustible tobacco. #GFN25 Science Lab discussions

This GFN Voices 2025 episode brings together advocates, scientists and campaigners from around the world to share why the Global Forum on Nicotine matters, how tobacco harm reduction is being misunderstood, and why honest communication, access to safer products and open debate are essential for helping people move away from smoking.

In this episode of Science Lab, we break down new clinical evidence on how Heated Tobacco Products (HTPs) compare to traditional cigarettes in terms of respiratory health. Using biomarker data, symptom tracking, and real-world study outcomes, she explains what happens when smokers switch completely to HTPs — and how this transition may influence the incidence and severity of respiratory symptoms.

Nigeria is experiencing increasing health impacts from smoking, and experts argue that harm reduction—not prohibition—is key to saving lives. In this GFN News episode, Joanna Junak interviews Uche Olatunji and Yusuf Adebisi on the major barriers to tobacco harm reduction in Nigeria, including widespread misinformation about nicotine and a lack of educational resources. They discuss community outreach, science-based alternatives, and the critical roles of universities and the media in shifting public perception. Learn how evidence-based harm-reduction strategies can help Nigerians make safer, informed decisions.

The media play a key role in shaping debates around THR. It is essential that information they communicate is accurate and reflects science and evidence. Misinformation and the impact it can have on consumers, and public health generally, is something we should avoid. A lack of knowledge, expertise and time to verify information provided – often by NGOs that allege to be working on behalf of public health – can lead to damaging narratives that serve nobody’s interest. How can we foster positive relationships with media to represent THR accurately and challenge those who seek to undermine it?